{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T17:17:34Z","timestamp":1769275054241,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Exp Biol Med"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s10517-026-06543-x","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:17:15Z","timestamp":1767889035000},"page":"654-658","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An MVA-Based Vector Expressing the SARS-CoV-2 RBD Fused to N Protein Induces Neutralizing Antibodies and T-Cell Immune Response in Mice"],"prefix":"10.1007","volume":"179","author":[{"given":"D. V.","family":"Glazkova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. R.","family":"Mintaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. V.","family":"Orlova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. V.","family":"Belugin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. A.","family":"Shipulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. V.","family":"Bogoslovskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"issue":"7","key":"6543_CR1","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","volume":"27","author":"DS Khoury","year":"2021","unstructured":"Khoury DS, Cromer D, Reynaldi A, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021;27(7):1205-11. https:\/\/doi.org\/10.1038\/s41591-021-01377-8","journal-title":"Nat Med."},{"issue":"1","key":"6543_CR2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41541-021-00393-6","volume":"6","author":"H Kleanthous","year":"2021","unstructured":"Kleanthous H, Silverman JM, Makar KW, et al. Scientific rationale for developing potent RBD-based vaccines targeting COVID-19. NPJ Vaccines. 2021;6(1):128. https:\/\/doi.org\/10.1038\/s41541-021-00393-6","journal-title":"NPJ Vaccines."},{"key":"6543_CR3","doi-asserted-by":"publisher","unstructured":"Liang Q, Wang Y, Zhang S, et al. RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants. iScience. 2022;25(4):104043. https:\/\/doi.org\/10.1016\/j.isci.2022.104043","DOI":"10.1016\/j.isci.2022.104043"},{"issue":"13","key":"6543_CR4","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1016\/j.cell.2022.04.029","volume":"185","author":"K Xu","year":"2022","unstructured":"Xu K, Gao P, Liu S, et al. Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2. Cell. 2022;185(13):2265-78.e14. https:\/\/doi.org\/10.1016\/j.cell.2022.04.029","journal-title":"Cell."},{"issue":"1","key":"6543_CR5","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41467-021-21665-8","volume":"12","author":"HX Tan","year":"2021","unstructured":"Tan HX, Juno JA, Lee WS, et al. Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques. Nat Commun. 2021; 12(1):1403. https:\/\/doi.org\/10.1038\/s41467-021-21665-8","journal-title":"Nat Commun."},{"issue":"2","key":"6543_CR6","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ymthe.2024.01.007","volume":"32","author":"J Yan","year":"2024","unstructured":"Yan J, Bangalore CR, Nikouyan N, et al. Distinct roles of vaccine-induced SARS-CoV-2-specific neutralizing antibodies and T cells in protection and disease. Mol Ther. 2024;32(2):540-55. https:\/\/doi.org\/10.1016\/j.ymthe.2024.01.007","journal-title":"Mol Ther."},{"issue":"2","key":"6543_CR7","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.3390\/ijms24021701","volume":"24","author":"A Kovalenko","year":"2023","unstructured":"Kovalenko A, Ryabchevskaya E, Evtushenko E, et al. Recombinant protein vaccines against human betacoronaviruses: strategies, approaches and progress. Int J Mol Sci. 2023;24(2):1701. https:\/\/doi.org\/10.3390\/ijms24021701","journal-title":"Int J Mol Sci."},{"issue":"10","key":"6543_CR8","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3390\/vaccines12101126","volume":"12","author":"S Notarbartolo","year":"2024","unstructured":"Notarbartolo S. T-cell immune responses to SARS-CoV-2 infection and vaccination. Vaccines (Basel). 2024;12(10):1126. https:\/\/doi.org\/10.3390\/vaccines12101126","journal-title":"Vaccines (Basel)."},{"key":"6543_CR9","doi-asserted-by":"publisher","first-page":"1217567","DOI":"10.3389\/fmicb.2023.1217567","volume":"14","author":"W Song","year":"2023","unstructured":"Song W, Fang Z, Ma F, et al. The role of SARS-CoV-2 N protein in diagnosis and vaccination in the context of emerging variants: present status and prospects. Front Microbiol. 2023;14:1217567. https:\/\/doi.org\/10.3389\/fmicb.2023.1217567","journal-title":"Front Microbiol."},{"issue":"23","key":"6543_CR10","doi-asserted-by":"publisher","DOI":"10.1172\/JCI162282","volume":"132","author":"T Dangi","year":"2022","unstructured":"Dangi T, Sanchez S, Class J, et al. Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibody. J Clin Invest. 2022;132(23):e162282. https:\/\/doi.org\/10.1172\/JCI162282","journal-title":"J Clin Invest."},{"issue":"9","key":"6543_CR11","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3390\/vaccines10091516","volume":"10","author":"OV Orlova","year":"2022","unstructured":"Orlova OV, Glazkova DV, Bogoslovskaya EV, et al. Development of modified vaccinia virus Ankara-based vaccines: advantages and applications. Vaccines (Basel). 2022;10(9):1516. https:\/\/doi.org\/10.3390\/vaccines10091516","journal-title":"Vaccines (Basel)."},{"key":"6543_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2020.114056","volume":"289","author":"OV Orlova","year":"2021","unstructured":"Orlova OV, Glazkova DV, Tsyganova GM, et al. Application of real-time PCR to significantly reduce the time to obtain recombinant MVA virus. J Virol Methods. 2021;289:114056. https:\/\/doi.org\/10.1016\/j.jviromet.2020.114056","journal-title":"J Virol Methods."},{"issue":"4","key":"6543_CR13","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3390\/vaccines11040831","volume":"11","author":"RR Mintaev","year":"2023","unstructured":"Mintaev RR, Glazkova DV, Orlova OV, et al. Develop ment of MVA-d34 tetravalent dengue vaccine: design and immunogenicity. Vaccines (Basel). 2023;11(4):831. https:\/\/doi.org\/10.3390\/vaccines11040831","journal-title":"Vaccines (Basel)."},{"issue":"1\u20132","key":"6543_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.cyto.2010.06.011","volume":"52","author":"DW Metzger","year":"2010","unstructured":"Metzger DW. Interleukin-12 as an adjuvant for induction of protective antibody responses. Cytokine. 2010;52(1-2):102-7. https:\/\/doi.org\/10.1016\/j.cyto.2010.06.011","journal-title":"Cytokine."},{"issue":"1","key":"6543_CR15","doi-asserted-by":"publisher","first-page":"4831","DOI":"10.1038\/s41467-022-32547-y","volume":"13","author":"JT Castro","year":"2022","unstructured":"Castro JT, Azevedo P, Fumagalli MJ., et al. Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein. Nat Commun. 2022;13(1):4831. https:\/\/doi.org\/10.1038\/s41467-022-32547-y","journal-title":"Nat Commun."},{"issue":"12","key":"6543_CR16","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.4049\/jimmunol.2200731","volume":"210","author":"F Mambelli","year":"2023","unstructured":"Mambelli F, Marinho FV, Andrade JM, et al. Recombinant Bacillus Calmette-Gu\u00e9rin expressing SARSCoV-2 chimeric protein protects K18-hACE2 mice against viral challenge. J Immunol. 2023;210(12):1925-37. https:\/\/doi.org\/10.4049\/jimmunol.2200731","journal-title":"J Immunol."},{"issue":"4","key":"6543_CR17","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3390\/vaccines10040516","volume":"10","author":"Z Hevesi","year":"2022","unstructured":"Hevesi Z, Gerges DA, Kapps S, et al. Preclinical Establishment of a divalent vaccine against SARS-CoV-2. Vaccines (Basel). 2022;10(4):516. https:\/\/doi.org\/10.3390\/vaccines10040516","journal-title":"Vaccines (Basel)."}],"container-title":["Bulletin of Experimental Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-026-06543-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10517-026-06543-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-026-06543-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T03:37:18Z","timestamp":1769225838000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10517-026-06543-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["6543"],"URL":"https:\/\/doi.org\/10.1007\/s10517-026-06543-x","relation":{},"ISSN":["0007-4888","1573-8221"],"issn-type":[{"value":"0007-4888","type":"print"},{"value":"1573-8221","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}